Sexual desire is not a fixed trait — it fluctuates in response to hormones, stress, relationship context, physical health, and the specific phase of the menstrual cycle. Understanding this natural variability can reduce anxiety about fluctuating desire and help individuals and couples navigate the rhythm of cyclical libido changes.
Testosterone, often conceptualized as primarily a male hormone, is produced by the ovaries and adrenal glands in women and plays the most direct role in sexual desire. Estrogen supports vaginal lubrication, tissue elasticity, and clitoral sensitivity. Progesterone, when elevated in the luteal phase, can reduce sexual interest in many women.
Research using daily diary methods has found consistent patterns in self-reported sexual desire across the cycle in women who are not using hormonal contraceptives. Desire tends to peak around ovulation — particularly in the 1-2 days surrounding the LH surge — when testosterone and estrogen are both elevated. A secondary rise in desire is often reported in the early follicular phase. The late luteal phase is typically associated with the lowest sexual interest, consistent with elevated progesterone and declining estrogen.
Some women report no effect on libido from hormonal contraceptives; others report significant reduction. A large Danish cohort study found that women using combined oral contraceptives reported lower sexual function scores than non-users. Possible mechanisms include suppression of ovarian testosterone production and increased sex hormone binding globulin which binds free testosterone. If you believe your contraceptive is affecting your libido, this is a legitimate clinical concern worth raising with your provider.
Genitourinary syndrome of menopause affects up to 50% of postmenopausal women and involves vaginal dryness, irritation, and pain with sex due to estrogen deficiency. It is highly treatable with topical estrogen. Vaginal moisturizers and lubricants provide symptom relief but do not treat the underlying tissue change.
Vaginismus — involuntary contraction of vaginal muscles in response to attempted penetration — affects approximately 1-7% of women and responds well to pelvic floor physical therapy, graduated dilation therapy, and psychological support.
Dyspareunia, pain with sex, should always be investigated rather than normalized. Causes include insufficient arousal, vaginismus, vulvodynia, endometriosis, pelvic inflammatory disease, and ovarian cysts. You deserve pain-free sex — if you are experiencing pain, please seek evaluation.
Research consistently shows that couples who communicate directly about sexual needs, preferences, and changes report higher sexual satisfaction and relationship quality. The cyclical nature of libido can be framed as information rather than a problem — sharing cycle tracking data with a partner can help contextualize natural fluctuations.